Peptidergic intraepidermal nerve fibers in the skin contribute to the neuropathic pain in paclitaxel-induced peripheral neuropathy

Neuropeptides

Volumn 48, Issue 3, 2014, Pages 109-117

  Ko, Miau Hwa ^a   Hu, Ming E ^b   Hsieh, Yu Lin ^c   Lan, Chyn Tair ^b   Tseng, To Jung ^a,b  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Calcitonin gene related peptide (CGRP); Chemotherapy induced peripheral neuropathy (CIPN); Neuropathic pain; Paclitaxel; Protein gene product 9.5 (PGP 9.5); Skin innervation; Substance P (SP)

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; PACLITAXEL; PROTEIN; PROTEIN GENE PRODUCT 9.5; SUBSTANCE P; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT;

ADULT; ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DENSITY; GLABROUS SKIN; HYPERALGESIA; IMMUNOREACTIVITY; LATENT PERIOD; MALE; NERVE DEGENERATION; NEUROPATHIC PAIN; NEUROTOXICITY; NONHUMAN; PAIN THRESHOLD; PEPTIDERGIC INTRAEPIDERMAL NERVE FIBER; PEPTIDERGIC NERVOUS SYSTEM; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RAT; SKIN NERVE; ANIMAL; CHEMICALLY INDUCED; DRUG EFFECTS; EPIDERMIS; INNERVATION; METABOLISM; NERVE FIBER; NEURALGIA; PATHOLOGY; SPRAGUE DAWLEY RAT; TOXICITY;

RATTUS;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CALCITONIN GENE-RELATED PEPTIDE; EPIDERMIS; MALE; NERVE DEGENERATION; NERVE FIBERS; NEURALGIA; PACLITAXEL; PERIPHERAL NERVOUS SYSTEM DISEASES; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANCE P;

EID: 84899909326     PISSN: 01434179     EISSN: 15322785     Source Type: Journal    
DOI: 10.1016/j.npep.2014.02.001     Document Type: Article

References (53)

1. Albers K.M., Woodbury C.J., Ritter A.M., Davis B.M., Koerber H.R. Glial cell-line-derived neurotrophic factor expression in skin alters the mechanical sensitivity of cutaneous nociceptors. J. Neurosci. 2006, 26:2981-2990.
2. Argyriou A.A., Polychronopoulos P., Koutras A., Xiros N., Petsas T., Argyriou K., Kalofonos H.P., Chroni E. Clinical and electrophysiological features of peripheral neuropathy induced by administration of cisplatin plus paclitaxel-based chemotherapy. Eur. J. Cancer Care 2007, 16:231-237.
3. Authier N., Gillet J.P., Fialip J., Eschalier A., Coudore F. Description of a short-term Taxol-induced nociceptive neuropathy in rats. Brain Res. 2000, 887:239-249.
4. Axelsson H.E., Minde J.K., Sonesson A., Toolanen G., Högestätt E.D., Zygmunt P.M. Transient receptor potential vanilloid 1, vanilloid 2 and melastatin 8 immunoreactive nerve fibers in human skin from individuals with and without Norrbottnian congenital insensitivity to pain. Neuroscience 2009, 162:1322-1332.
5. Bennett G.J., Liu G.K., Xiao W.H., Jin H.W., Siau C. Terminal arbor degeneration - a novel lesion produced by the antineoplastic agent paclitaxel. Eur. J. Neurosci. 2011, 33:1667-1676.
6. Binder A., Stenge M., Maag R., Wasner G., Schoch R., Moosig F., Schommer B., Baron R. Pain in oxaliplatin-induced neuropathy-sensitization in the peripheral and central nociceptive system. Eur. J. Cancer 2007, 43:2658-2663.
7. Bogen O., Joseph E.K., Chen X., Levine J.D. GDNF hyperalgesia is mediated by PLCγ, MAPK/ERK, PI3K, CDK5 and Src family kinase signaling and dependent on the IB4-binding protein versican. Eur. J. Neurosci. 2008, 28:12-19.
8. Boyette-Davis J., Dougherty P.M. Protection against oxaliplatin-induced mechanical hyperalgesia and intraepidermal nerve fiber loss by minocycline. Exp. Neurol. 2011, 229:353-357.
9. Cata J.P., Weng H.R., Lee B.N., Reuben J.M., Dougherty P.M. Clinical and experimental findings in humans and animals with chemotherapy-induced peripheral neuropathy. Minerva Anestesiol. 2006, 72:151-169.
10. Cavaletti G., Tredici G., Braga M., Tazzari S. Experimental peripheral neuropathy induced in adult rats by repeated intraperitoneal administration of taxol. Exp. Neurol. 1995, 133:64-72.
11. Chiang H.Y., Chen C.T., Chien H.F., Hsieh S.T. Skin denervation, neuropathology, and neuropathic pain in a laser-induced focal neuropathy. Neurobiol. Dis. 2005, 18:40-53.
12. Cliffer K.D., Siuciak J.A., Carson S.R., Radley H.E., Park J.S., Lewis D.R., Zlotchenko E., Nguyen T., Garcia K., Tonra J.R., Stambler N., Cedarbaum J.M., Bodine S.C., Lindsay R.M., DiStefano P.S. Physiological characterization of Taxol-induced large-fiber sensory neuropathy in the rat. Ann. Neurol. 1998, 43:46-55.
13. Dougherty P.M., Cata J.P., Burton A.W., Vu K., Weng H.R. Dysfunction in multiple primary afferent fiber subtypes revealed by quantitative sensory testing in patients with chronic vincristine-induced pain. J. Pain Symptom Manage. 2007, 33:166-179.
14. Flatters S.J.L., Bennett G.J. Ethosuximide reverses paclitaxel- and vincristine-induced painful peripheral neuropathy. Pain 2004, 109:50-61.
15. Flatters S.J.L., Bennett G.J. Studies of peripheral sensory nerves in paclitaxel-induced painful peripheral neuropathy - evidence for mitochondrial dysfunction. Pain 2006, 122:247-257.
16. Gracias N.G., Cummins T.R., Kelley M.R., Basile D.P., Iqbal T., Vasko M.R. Vasodilatation in the rat dorsal hindpaw induced by activation of sensory neurons is reduced by paclitaxel. Neurotoxicology 2011, 32:140-149.
17. Hsiao T.H., Fu Y.S., Ho W.Y., Chen T.H., Hsieh Y.L. Promotion of thermal analgesia and neuropeptidergic skin reinnervation by 4-methylcatechol in resiniferatoxin-induced neuropathy. Kaohsiung J. Med. Sci. 2013, 29:405-411.
18. Hsieh S.T., Chiang H.Y., Lin W.M. Pathology of nerve terminal degeneration in the skin. J. Neuropathol. Exp. Neurol. 2000, 59:297-307.
19. Hsieh Y.L., Lin C.L., Chiang H., Fu Y.S., Lue J.H., Hsieh S.T. Role of peptidergic nerve terminals in the skin: reversal of thermal sensation by calcitonin gene-related peptide in TRPV1-depleted neuropathy. PLoS ONE 2012, 7:e50805.
20. IASP Committee Ethical standards for investigations of experimental pain in animals. The Committee for Research and Ethical Issues of the International Association for the Study of Pain. Pain 1980, 9:141-143.
21. Jaggi A.S., Singh N. Therapeutic targets for the management of peripheral nerve injury-induced neuropathic pain. CNS Neurol. Disord.: Drug Targets 2011, 10:589-609.
22. Jamieson S.M., Liu J., Connor B., McKeage M.J. Oxaliplatin causes selective atrophy of a subpopulation of dorsal root ganglion neurons without inducing cell loss. Cancer Chemother. Pharmacol. 2005, 56:391-399.
23. Jin H.W., Flatters S.J.L., Xiao W.H., Mulhern H.L., Bennett G.J. Prevention of paclitaxel-evoked painful peripheral neuropathy by acetyl-Lcarnitine - effects on axonal mitochondria, sensory nerve fiber terminal arbors, and cutaneous Langerhans cells. Exp. Neurol. 2008, 210:229-237.
24. Jordan M.A., Wilson L.M. Microtubules as a target for anticancer drugs. Nat. Rev. Cancer 2004, 4:253-265.
25. Kawashiri T., Egashira N., Itoh Y., Shimazoe T., Ikegami Y., Yano T., Yoshimura M., Oishi R. Neurotropin reverses paclitaxel-induced neuropathy without affecting anti-tumour efficacy. Eur. J. Cancer 2009, 45:154-163.
26. Kennedy W.R. Opportunities afforded by the study of unmyelinated nerves in skin and other organs. Muscle Nerve 2004, 29:756-767.
27. Ko M.H., Chen W.P., Hsieh S.T. Neuropathology of skin denervation in acrylamide-induced neuropathy. Neurobiol. Dis. 2002, 11:155-165.
28. Lee J.J., Swain S.M. Development of novel chemotherapeutic agents to evade the mechanisms of multidrug resistance (MDR). Semin. Oncol. 2005, 32:S22-S26. (Review).
29. Lipton R.B., Apfel S.C., Dutcher J.P., Rosenberg R., Kaplan J., Berger A., Einzig A.I., Wiernik P., Schaumburg H.H. Taxol produces a predominantly sensory neuropathy. Neurology 1989, 39:368-373.
30. Ma W., Bisby M.A. Calcitonin gene-related peptide, substance P and protein gene product 9.5 immunoreactive axonal fibers in the rat footpad skin following partial sciatic nerve injuries. J. Neurocytol. 2000, 29:249-262.
31. Materazzi S., Fusi C., Benemei S., Pedretti P., Patacchini R., Nilius B., Prenen J., Creminon C., Geppetti P., Nassini R. TRPA1 and TRPV4 mediate paclitaxel-induced peripheral neuropathy in mice via a glutathione-sensitive mechanism. Pflugers Arch. 2012, 463:561-569.
32. McCarthy B., Hsieh S.T., Stocks E.A., Hauer P., Macko C., Cornblath D.R. Cutaneous innervation in sensory neuropathies: evaluation by skin biopsy. Neurology 1995, 45:1848-1855.
33. Miyano K., Tang H.B., Nakamura Y., Morioka N., Inoue A., Nakata Y. Paclitaxel and vinorelbine, evoked the release of substance P from cultured rat dorsal root ganglion cells through different PKC isoform-sensitive ion channels. Neuropharmacology 2009, 57:25-32.
34. Monsarrat B., Mariel E., Cros S., Gare's M., Guénard D., Guéritte-Voegelein F., Wright M. Taxol metabolism. Isolation and identification of three major metabolites of taxol in rat bile. Drug Metab. Dispos. 1990, 18:895-901.
35. Park S.B., Goldstein D., Lin C.S.Y., Krishnan A.V., Friedlander M., Kiernan M.C. Acute abnormalities of sensory nerve function associated with oxaliplatin-induced neurotoxicity. J. Clin. Oncol. 2009, 27:1243-1249.
36. Peleshok J.C., Ribeiro-da-Silva A. Delayed reinnervation by nonpeptidergic nociceptive afferents of the glabrous skin of the rat hindpaw in a neuropathic pain model. J. Comp. Neurol. 2011, 519:49-63.
37. Polomano R.C., Mannes A.J., Clark U.S., Bennett G.J. A painful peripheral neuropathy in the rat produced by the chemotherapeutic drug, paclitaxel. Pain 2001, 94:293-304.
38. Quasthoff S., Hartung H.P. Chemotherapy-induced peripheral neuropathy. J. Neurol. 2002, 249:9-17.
39. Rowinsky E.K., Eisenhauer E.A., Chaudhry V., Arbuck S.G., Donehower R.C. Clinical toxicities encountered with paclitaxel (Taxol). Semin. Oncol. 1993, 20:1-15.
40. Ruscheweyh R., Forsthuber L., Schoffnegger D., Sandkühler J. Modification of classical neurochemical markers in identified primary afferent neurons with Abeta-, Adelta-, and C-fibers after chronic constriction injury in mice. J. Comp. Neurol. 2007, 502:325-336.
41. Schmidt Y., Unger J.W., Bartke I., Reiter R. Effect of nerve growth factor on peptide neurons in dorsal root ganglia after taxol or cisplatin treatment and in diabetic (db/db) mice. Exp. Neurol. 1995, 132:16-23.
42. Siau C., Xiao W., Bennett G.J. Paclitaxel- and vincristine-evoked painful peripheral neuropathies: loss of epidermal innervation and activation of Langerhans cells. Exp. Neurol. 2006, 201:507-514.
43. Tatsushima Y., Egashira N., Kawashiri T., Mihara Y., Yano T., Mishima K., Oishi R. Involvement of substance P in peripheral neuropathy induced by paclitaxel but not oxaliplatin. J. Pharmacol. Exp. Ther. 2011, 337:226-235.
44. Taylor A.M., Peleshok J.C., Ribeiro-da-Silva A. Distribution of P2X(3)-immunoreactive fibers in hairy and glabrous skin of the rat. J. Comp. Neurol. 2009, 514:555-566.
45. Taylor A.M., Osikowicz M., Ribeiro-da-Silva A. Consequences of the ablation of nonpeptidergic afferents in an animal model of trigeminal neuropathic pain. Pain 2012, 153:1311-1319.
46. Tseng T.J., Chen C.C., Hsieh Y.L., Hsieh S.T. Effects of decompression on neuropathic pain behaviors and skin reinnervation in chronic constriction injury. Exp. Neurol. 2007, 204:574-582.
47. Tseng T.J., Chen C.C., Hsieh Y.L., Hsieh S.T. Influences of surgical decompression on the dorsal horn after chronic constriction injury: changes in peptidergic and δ-opioid receptor (+) nerve terminals. Neuroscience 2008, 156:758-768.
48. Wani M.C., Taylor H.L., Wall M.E., Coggon P., McPhail A.T. Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. J. Am. Chem. Soc. 1971, 93:2325-2327.
49. Wolf S., Barton D., Kottschade L., Grothey A., Loprinzi C. Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies. Eur. J. Cancer 2008, 44:1507-1515.
50. Xiao W.H., Bennett G.J., Bordet T., Pruss R.M. Olesoxime (cholest-4-en-3-one, oxime) - analgesic and neuroprotective effects in a rat model of painful peripheral neuropathy produced by the chemotherapeutic agent, paclitaxel. Pain 2009, 147:202-209.
51. Yen L.D., Bennett G.J., Ribeiro-da-Silva A. Sympathetic sprouting and changes in nociceptive sensory innervation in the glabrous skin of the rat hind paw following partial peripheral nerve injury. J. Comp. Neurol. 2006, 495:679-690.
52. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 1983, 16:109-110.
53. Zylka M.J., Dong X., Southwell A.L., Anderson D.J. Atypical expansion in mice of the sensory neuron-specific Mrg G-protein-coupled receptor family. Proc. Natl. Acad. Sci. USA 2003, 100:10043-10048.